Judith R Kroep, MD PhD
Medical Oncology, Leiden University Medical Center · Leiden University Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Judith R Kroep, MD PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:55 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05255653 · Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular FeaturesLeiden University Medical Center · recruiting · Endometrial Cancer · principal investigator
- N/ANCT03862677 · Determining Prognostic Immune Markers in Patients With Ovarian CancerLeiden University Medical Center · recruiting · Epithelial Ovarian Cancer · principal investigator
- Ph2NCT03532087 · Study to Identify the Impact of Denosumab on the Immune System in Patients With HER2 Negative Breast CancerBorstkanker Onderzoek Groep · withdrawn · Breast Neoplasms · principal investigator
- Ph2NCT03283384 · Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.Borstkanker Onderzoek Groep · active not recruiting · Breast Neoplasms · principal investigator
- Ph2/Ph3NCT02126449 · DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast CancerLeiden University Medical Center · completed · Fasting Mimicking Diet, Breast Cancer, Neoadjuvant Chemotherapy · principal investigator
- Ph1/Ph2NCT01639885 · Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian CancerLeiden University Medical Center · completed · Recurrent Ovarian Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.